Delta Sleep Inducing Peptide (DSIP) is a naturally occurring nonapeptide composed of nine amino acids. It was originally isolated from the central nervous system in experimental models associated with electrically induced sleep states. Based on early observations, DSIP has been studied in laboratory research for its potential involvement in sleep related signaling pathways.
In experimental settings, DSIP has been examined for its association with delta-wave activity and electrophysiological processes within the brain. Research literature explores its interaction with neurotransmitter systems, investigating whether DSIP may influence neurochemical balance and signaling dynamics under controlled conditions.
DSIP was first characterized in scientific studies conducted between the 1960s and 1970s, after which broader research interest expanded beyond sleep related mechanisms. Subsequent investigations evaluated DSIP in experimental models for its potential relevance to nociception related signaling, stress response pathways, and neurochemical regulationassociated with behavioral and physiological states.
DSIP is supplied strictly for laboratory and in vitro research use only. This compound is not intended for human or animal consumption, clinical application, diagnostic use, or therapeutic purposes.
DSIP is supplied strictly for research use only and is not intended for human or animal consumption, clinical application, diagnostic use, or therapeutic purposes.
